ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D10AF02 | G | Erythromycin - 40mg/ml | 4439 | 236679/99 | MED-ERYTHROMYCIN 4% | 4% | 60ml | Solution | Topical | Medapharm Healthcare SAL | Mediphar Laboratories | Lebanon | 235,492 L.L | 23.08 | A1 | 12/12/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D10AF02 | B | Erythromycin base - 40mg/ml | 2767 | 26674 | ERYFLUID | 4% | 100ml | Lotion | Topical | Mersaco | Pierre Fabre Medicament Production | France | 486,471 L.L | 23.08 | A1 | 12/12/20 | 0 | ||
D10AF02 | B | Erythromycin base - 4% | 11805 | 130323/1 | ERYFLUID | 4% | 100ml | Lotion | Topical | Mersaco | Pierre Fabre Medicament Production | France | 486,471 L.L | 23.08 | A1 | Pierre Fabre Medicament | France | 12/12/20 | 0 |